(2E)-1-(3-bromophenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

2,3,3,3-Tetrafluoropropanoic acid, 97.0%, 1g

6-(4-chlorophenoxy)pyridin-3-amine, 97%, 100mg

4-Quinazolinamine, N-(1-cyclohexyl-4-piperidinyl)-2-[hexahydro-4-(1-methylethyl)-1H-1,4-diazepin-1-yl]-6-methoxy-7-[3-(1-piperidinyl)propoxy]-, 98%, 5mg

3-Methyl-1-p-tolyl-1H-pyrazole-5-carboxylic acid, 97.0%, 10g

Adamantane, 99.0%, 500g

5-(4-pyridinyl)-1H-pyrazol-3-amine dihydrochloride, 95.0%, 10g

tert-Butyl 3-bromoazetidine-1-carboxylate, 95.0%, 1g

Flacone tondo da 125 ml HDPE bianco RD 18 cilindrico

(2s)-2-(1-Oxo-2,3-dihydro-1h-isoindol-2-yl)-3-phenylpropanoic acid, 95%, 500mg

3-nitrobenzene-1-carbothioamide, 95.0%, 10g

4-chloro-4'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone, 97.0%, 1g

Methyl 3-oxo-3-phenylpropanoate, 95.0%, 1g